lobbying_filings_raw: 5251277d-1ddc-4e4e-a54d-5a72cebdc446
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | is_amendment | is_no_activity | is_termination | raw_json | registrant_state | registrant_country | registrant_house_id | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | affiliated_org_count | client_entity_id | client_government_unit_id | client_match_method | client_match_confidence | income_amount | expense_amount |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5251277d-1ddc-4e4e-a54d-5a72cebdc446 | Q2 | 286074 | PHARMAVITE LLC | 176428 | PHARMAVITE LLC | 2021 | second_quarter | 2021-07-12T15:28:07.197000-04:00 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/5251277d-1ddc-4e4e-a54d-5a72cebdc446/", "filing_uuid": "5251277d-1ddc-4e4e-a54d-5a72cebdc446", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2021, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/5251277d-1ddc-4e4e-a54d-5a72cebdc446/print/", "filing_document_content_type": "text/html", "income": null, "expenses": "80000.00", "expenses_method": "a", "expenses_method_display": "Method A - Reporting amounts using LDA definitions only", "posted_by_name": "Ingrid Lebert", "dt_posted": "2021-07-12T15:28:07.197000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "8531 Fallbrook Ave.", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "West Hills", "registrant_state": "CA", "registrant_zip": "91304", "registrant": {"id": 286074, "url": "https://lda.senate.gov/api/v1/registrants/286074/", "house_registrant_id": 36957, "name": "PHARMAVITE LLC", "description": null, "address_1": "8531 Fallbrook Ave.", "address_2": null, "address_3": null, "address_4": null, "city": "West Hills", "state": "CA", "state_display": "California", "zip": "91304", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "INGRID LEBERT", "contact_telephone": "+1 202-492-4486", "dt_updated": "2026-03-05T12:26:01.923676-05:00"}, "client": {"id": 176428, "url": "https://lda.senate.gov/api/v1/clients/176428/", "client_id": 12, "name": "PHARMAVITE LLC", "general_description": null, "client_government_entity": false, "client_self_select": true, "state": "CA", "state_display": "California", "country": "US", "country_display": "United States of America", "ppb_state": "CA", "ppb_state_display": "California", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2007-08-03"}, "lobbying_activities": [{"general_issue_code": "BUD", "general_issue_code_display": "Budget/Appropriations", "description": "Increase funding for the Office of Dietary Supplement Programs at FDA", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CPT", "general_issue_code_display": "Copyright/Patent/Trademark", "description": "H.R. 3429, Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce (SHOP SAFE) Act, a bill to amend the Trademark Act of 1946 to provide for contributory liability for certain electronic commerce platforms for use of a counterfeit mark by a third party on such platforms, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MAN", "general_issue_code_display": "Manufacturing", "description": "S. 297, Reinforcing American-Made Products Act, a bill to make exclusive the authority of the Federal Government to regulate the labeling of products made in the United States and introduced in interstate or foreign commerce, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "ENV", "general_issue_code_display": "Environment/Superfund", "description": "S. 984, Break Free from Plastic Pollution Act, a bill to amend the Solid Waste Disposal Act to reduce the production and use of certain single-use plastic products and packaging, to improve the responsibility of producers in the design, collection, reuse, recycling, and disposal of their consumer products and packaging, to prevent pollution from consumer products and packaging from entering into animal and human food chains and waterways, and for other purposes; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "CSP", "general_issue_code_display": "Consumer Issues/Safety/Products", "description": "H.R. 1816, Information Transparency & Personal Data Control Act, a bill to require the Federal Trade Commission to promulgate regulations related to sensitive personal information, and for other purposes; all provisions relating to dietary supplements.\nS. 1667, Social Media Privacy Protection and Consumer Rights Act, a bill to protect the privacy of users of social media and other online platforms; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "FOO", "general_issue_code_display": "Food Industry (safety, labeling, etc.)", "description": "H.R. 841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, a bill to make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement; all provisions relating to dietary supplements.\nS. 1698, Hemp Access and Consumer Safety Act, a bill to allow for hemp-derived cannabidiol and hemp-derived cannabidiol containing substances in dietary supplements and food; all provisions relating to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": true}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "S. 380, Health Savings Act, a bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts; all provisions related to dietary supplements.\nS. 1654, a bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses; all provisions related to dietary supplements.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 71867, "prefix": null, "prefix_display": null, "first_name": "INGRID", "nickname": null, "middle_name": null, "last_name": "LEBERT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} | CA | US | 36957 | CA | CA | US | US | 0 | 0 | 80000.0 |